Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Outcome of Non-Germinal Center/Activated B-Cell Type Diffuse Large B-Cell Lymphoma Determined By Immunohistochemistry in a Single Institution over 7 Years

Marian Girgis, MD, Joyce Philip, MD, Zora Cvetkovski Injic, Edward M. Peres, MD, Madhu P. Menon, MD PhD, Shatha Y. Farhan, MD, Nalini Janakiraman, MD

Blood (2017) 130 (Supplement 1): 5224.

https://doi.org/10.1182/blood.V130.Suppl_1.5224.5224

Published: 2017

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplant in Older Patients with Myelodysplastic Syndrome and Co-Existing Myelofibrosis: A Single Center Experience and Review of the Literature

Abhijit B Saste, Philip Kuriakose, MD, Nalini Janakiraman, MD, Edward Peres, MD, Shatha Y. Farhan, MD

Blood (2016) 128 (22): 5850.

https://doi.org/10.1182/blood.V128.22.5850.5850

Published: 2016

Journal Articles

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Shatha Y. Farhan, MD, George Divine, PhD, Klodiana Neme, PharmD, Danielle Pelland, Susan Wautelet, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Edward Peres, MD, Nalini Janakiraman, MD

Blood (2015) 126 (23): 5446.

https://doi.org/10.1182/blood.V126.23.5446.5446

Published: 2015

Journal Articles

Erythrocytapheresis in Sickle Cell Disease and Multi-Organ Failure in the Intensive Care Unit.

Shatha Y. Farhan, MD, Ileana Lopez_Plaza, MD

Blood (2009) 114 (22): 4627.

https://doi.org/10.1182/blood.V114.22.4627.4627

Published: 2009

Journal Articles

R-CHOP Every Two Weeks with Pegylated Filgastrim Support for the Treatment of CD20+ Aggressive Non Hodgkin's Lymphoma: Feasibility of Delivery On Time.

Shatha Y. Farhan, MD, Tim Kasunic, MD, George Divine, PhD, Philip Kuriakose, MD, Nalini Janakiraman, MD

Blood (2009) 114 (22): 4773.

https://doi.org/10.1182/blood.V114.22.4773.4773

Published: 2009

NARROW

Outcome of Non-Germinal Center/Activated B-Cell Type Diffuse Large B-Cell Lymphoma Determined By Immunohistochemistry in a Single Institution over 7 Years

Outcomes of Hematopoietic Stem Cell Transplant in Older Patients with Myelodysplastic Syndrome and Co-Existing Myelofibrosis: A Single Center Experience and Review of the Literature

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Erythrocytapheresis in Sickle Cell Disease and Multi-Organ Failure in the Intensive Care Unit.

R-CHOP Every Two Weeks with Pegylated Filgastrim Support for the Treatment of CD20+ Aggressive Non Hodgkin's Lymphoma: Feasibility of Delivery On Time.

Email alerts

ASH Publications

American Society of Hematology

Outcome of Non-Germinal Center/Activated B-Cell Type Diffuse Large B-Cell Lymphoma Determined By Immunohistochemistry in a Single Institution over 7 Years

Outcomes of Hematopoietic Stem Cell Transplant in Older Patients with Myelodysplastic Syndrome and Co-Existing Myelofibrosis: A Single Center Experience and Review of the Literature

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Erythrocytapheresis in Sickle Cell Disease and Multi-Organ Failure in the Intensive Care Unit.

R-CHOP Every Two Weeks with Pegylated Filgastrim Support for the Treatment of CD20+ Aggressive Non Hodgkin's Lymphoma: Feasibility of Delivery On Time.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only